Insufficient scRNA-seq data for expression of SPINK9 at single-cell level.
Insufficient scRNA-seq data for expression of SPINK9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 83% | 4.92 | 213 / 258 | 4% | 0.08 | 10 / 230 |
brain | 82% | 6.65 | 2162 / 2642 | 1% | 0.01 | 4 / 705 |
thymus | 74% | 2.65 | 486 / 653 | 5% | 0.07 | 32 / 605 |
pancreas | 76% | 3.18 | 249 / 328 | 3% | 0.07 | 5 / 178 |
heart | 77% | 4.19 | 666 / 861 | 0% | 0 | 0 / 0 |
prostate | 69% | 3.13 | 170 / 245 | 2% | 0.02 | 8 / 502 |
ovary | 66% | 2.16 | 118 / 180 | 0% | 0.00 | 1 / 430 |
uterus | 61% | 1.44 | 103 / 170 | 2% | 0.04 | 9 / 459 |
intestine | 54% | 1.34 | 522 / 966 | 1% | 0.01 | 3 / 527 |
bladder | 52% | 1.33 | 11 / 21 | 2% | 0.08 | 11 / 504 |
lung | 48% | 1.16 | 280 / 578 | 4% | 0.15 | 43 / 1155 |
breast | 50% | 1.31 | 228 / 459 | 1% | 0.03 | 10 / 1118 |
skin | 49% | 1.43 | 886 / 1809 | 1% | 0.03 | 5 / 472 |
stomach | 47% | 1.08 | 169 / 359 | 1% | 0.03 | 4 / 286 |
liver | 48% | 1.10 | 108 / 226 | 0% | 0 | 0 / 406 |
esophagus | 47% | 1.07 | 681 / 1445 | 1% | 0.01 | 1 / 183 |
kidney | 45% | 1.38 | 40 / 89 | 1% | 0.07 | 10 / 901 |
spleen | 42% | 0.80 | 102 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 41% | 0.76 | 553 / 1335 | 0% | 0 | 0 / 0 |
adipose | 37% | 0.76 | 443 / 1204 | 0% | 0 | 0 / 0 |
muscle | 28% | 0.53 | 226 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 18% | 0.30 | 164 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005576 | Cellular component | extracellular region |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SPINK9 |
Protein name | Serine peptidase inhibitor Kazal type 9 Serine protease inhibitor Kazal-type 9 (Lymphoepithelial Kazal-type-related inhibitor 2) |
Synonyms | LEKTI2 |
Description | FUNCTION: Serine protease inhibitor which specifically inhibits KLK5. May contribute to the regulation of the desquamation process in skin by inhibiting KLK5. . |
Accessions | Q5DT21 ENST00000377906.2 D6RJC5 ENST00000511717.6 |